可立苏治疗新生儿肺透明膜病的临床观察

目的：探讨可立苏联合经鼻正压通气（NCPAP）治疗新生儿肺透明膜病的疗效.方法：68例新生儿肺透明膜病,随机分成可立苏＋NCPAP组和NCPAP组,比较治疗前后血气分析、治疗转归、并发症.结果：可立苏＋NCPAP组在PaO2、SaO2均好于NCPAP组,差异具有统计学意义（P〈0.05）; 可立苏＋NCPAP组临床治疗效果优于NCPAP组（P〈0.05）.2组并发症比较无统计学差异（P〉0.05）.结论：可立苏联合NCPAP治疗新生儿肺透明膜病可明显改善患儿通气和换气,临床效果好.

Clinical Study on Effects of Pulmonary Surfactant combined NCPAP on the Treatment in NRDS

Objective：To investigate effects of Pulmonary Suffactant combined NCPAP on the Treatment in NRDS. Meth- ods ：68 cases of NRDS Were randomly divided into 2 groups：（PS） ＋ （NCPAP）group, NCPAP group, comparing blood gas analysis, treatment outcome, complications. Resldts： pH, Pat2, PaCt2, Sat2 of （PS） ＋ （NCPAP） group were better than that of NCPAP group, the difference was statistically significant （ P 〈 0.05 ） ; The clinical treatment effect of （ PS ） ＋ （NCPAP） group was better than that of NCPAP group （ P 〈 0.05 ）. Comparison of the complications ： No significant differ- ence between 2 groups （ P 〉 0.05 ）. Conclusion： The treatment of pulmonary surfactant combined NCPAP to NRDS can significantly improve children ventilation. The Clinical effect is good, worthy of promotion.